KPJ Damansara launches dengue prevention awareness campaignAugust 27, 2024
Dengue fever is a serious global health threat, affecting millions of people each year. Dengue is one of the top ten global health threats as listed by the World Health Organisation (WHO) in 2019. As of 30 April this year, over 7 million dengue cases have been reported worldwide, surpassing the total annual cases reported in 2023.
Dengue is hyper-endemic in Malaysia. In the first 6 months of 2024, the Ministry of Health (MoH) reported 75,263 cases and 60 deaths, marking a 27% increase in cases and a 50% increase in deaths compared to the same period last year. There is currently no definitive curative treatment for dengue, and no antiviral is available. Clinical management of dengue is mainly supportive. Additionally, individuals who are infected for the second time are at greater risk of severe dengue, which can be fatal. Effective prevention and control measures Recognising the urgent need for prevention, KPJ Damansara Specialist Hospital in collaboration with Takeda Malaysia Sdn Bhd, marked a significant milestone on 24 August by hosting the “Dengue and Merdeka” awareness event. Coinciding with Malaysia’s 67th Independence Day, the event celebrated the launch of the dengue vaccination programme, a crucial step forward in combating this widespread disease. The event was inaugurated by Nurul Izzah Anwar, Chairperson of the Social & Economic Research Initiative (SERI), who stated, “Dengue has long been a challenge for our country. Despite intensive efforts by the government, such as widespread mosquito control programmes and community engagement in eliminating breeding sites, Malaysia continues to grapple with a high burden of dengue fever cases.” Earlier, Dato’ Mohamad Farid Salim, Chief Operating Officer (COO) of KPJ Healthcare Berhad reminded guests to remain vigilant against the health threats we face, particularly the growing risk of dengue. According to the World Health Organization, nearly half of the world's population is now at risk of dengue. This is a powerful reminder that we must stay proactive in safeguarding our health. Dato’ Dr Musa Mohd Nordin, a paediatrician at KPJ Damansara Specialist Hospital, in his talk titled “Merdeka and Dengue”, urged all eligible individuals over 4 years old to consider taking the dengue vaccine, which has been shown to reduce the risk of contracting dengue and decreases the risk of hospitalisation by 84%. There have been no major adverse effects associated with the dengue vaccine.” The event was graced by the presence of esteemed guests, including Professor Dato' Dr Azizi Haji Omar, Member of the Board of Directors & Group Medical Advisor of KPJ Healthcare Berhad; Hoo Ling Lee, Regional Chief Executive Officer (RCEO) of KPJ Healthcare Berhad; Dr Nur Abdul Karim, Medical Director of KPJ Damansara Specialist Hospital; Sharian Hussain, Chief Executive Officer (CEO) of KPJ Damansara Specialist Hospital; Sony Paul, Head of Franchise, Vaccines Malaysia and Singapore (Takeda), along with members of the hospital community and the public. The audience was also treated to a performance by the Senior Citizens Club Subang Jaya Symphony Choir (SCCSJ Symphony Choir), who performed "Jiwa Merdeka." This stirring performance not only celebrated Malaysia’s independence but also highlighted the unity and resilience required in the ongoing fight against dengue. |
EXPLORE FURTHER
Illumina and ScienceVision selected as sequencing technology partners for MyGenom projectMyGenom project to sequence 10,000 Malaysian genomes
|
Pantai Hospital (KL) introduces Outpatient Parenteral Antimicrobial Therapy (OPAT)Outpatient IV antimicrobial therapy eliminates need for extended hospitalization
|
Maaedicare fundraiser ball delivers RM500,000 boost for kidney, cardiac patientsSupporting free dialysis, heart health services, and free healthcare at 'Klinik Amal Percuma' for 256 patients
|
National Heart Institute (IJN) introduces Evolut FX device to treat aortic stenosisAddressing the needs of patients with small aortic annulus
|
Learn to save lives: Join our basic life support (BLS) courseDamai Pain Care & Wellness, in collaboration with Universiti Malaysia Sabah, offers BLS course led by AHA-certified instructors
|
Duopharma Biotech explores collaboration in halal pharmaceuticals at Doha roundtablePromising potential highlighted for bilateral relations between Malaysia - Qatar
|
Regency Specialist Hospital enters Malaysian Book of Records with diabetes screening campaign3,148 participants screened within three days
|
Sunway Medical Centre launches CSR radiotherapy program for cancer in SarawakSarawak ranks as the state with the 5th highest cancer incidence rates
|
EncoreMed shines brights at APHM conference, redefining healthcare with unified hospital digital solutionReducing hospital congestion by 50%
|
DKSH offers support to shelter home for children50 volunteers dedicate their efforts to create a comfortable environment
|
New ERT Nexviazyme approved for treatment of Pompe diseaseImproving lung function, walking distance, and muscle strength
|
Aurelius Healthcare and Rizman Ruzaini enhance staff uniforms across departments13 carefully crafted sets for easy identification
|
Taking quality lumbar support to new heightsWorld's first cordless massage chair debuts on the peak of Mount Kinabalu
|
DKSH Malaysia - Botrem partner to revolutionize skin rehabilitationTargeted solutions for persistent allergies
|
Duopharma Biotech - Owen Mumford partners to distribute medical devicesDiabetes and eye care products to be distributed as part of the agreement
|
Columbia Asia sets foot in Bukit JalilSeven-story hospital offering 96 ward beds and multi-specialties
|
Sunway Medical Centre Velocity introduces robotic surgery serviceA minimally invasive alternative to laparoscopic surgery
|
Danone Malaysia - the first food company to be certified B CorporationAdvocate of Iron Deficiency Anaemia (IDA) among Malaysian children
|
Preserving female cancer patients' fertility via cryopreservationIdeal for girls pre-puberty and women in reproductive age
|
Monurol (Fosfomycin Trometamol) receives DCA approval for transrectal prostate biopsy in adult menNew indication of perioperative antibiotic prophylaxis
|
Roche-MUIS announce funding for breast cancer patientsAccess to neoadjuvant therapy for HER-2 positive breast cancer patients
|
5-year-old Khaivan gains hearing ability through cochlear implant surgeryAudiolab's hearing solutions bring hope to those with hearing loss
|
Mahkota Medical Centre earns CCPC accreditation for breast cancerRM250 million investment towards healthcare transformation
|
UMW Toyota's generous donation bolsters cancer society's vital servicesExpanding cancer care reach and access
|